Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Pyoderma Gangrenosum
Interventions: Dehydrated human amnion/chorion membrane; Biological
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Metairie, Louisiana • New Orleans, Louisiana

Conditions: Clostridium Difficile
Interventions: Serum-derived bovine immunoglobulin/protein isolate (SBI), Placebo; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: Miami, Florida • Chicago, Illinois

Conditions: Diabetic Foot Ulcer
Interventions: HO/03/03 10µg, Placebo; Drug
Lead sponsor: HealOr; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 19
States / cities: Phoenix, Arizona • Castro Valley, California • Long Beach, California + 14 more

Conditions: Colitis, Ulcerative
Interventions: ST-0529; Drug
Lead sponsor: Sublimity Therapeutics Holdco Limited; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 8
States / cities: Palm Springs, California • Largo, Florida • New Port Richey, Florida + 4 more

Conditions: Fusarium Keratitis
Interventions: Rose Bengal Photodynamic Therapy, Sham RB-PDT; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 434 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Palo Alto, California • Miami, Florida

Conditions: Diabetic Foot Infection
Interventions: Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care; Drug · Other
Lead sponsor: Dipexium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 39
States / cities: Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 36 more

Conditions: Ulcerative Colitis
Interventions: Urinary PGEm level, fecal calprotectin; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Diabetic Foot Ulcer
Interventions: Standard of Care, NeoThelium FT; Other
Lead sponsor: NuScience Medical Biologics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Alexandria, Louisiana • Franklinton, Louisiana • Hammond, Louisiana + 5 more

Conditions: Ulcerative Colitis
Interventions: placebo, rhuMAb Beta7; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 8
States / cities: Anniston, Alabama • San Francisco, California • Gainesville, Florida + 5 more

Conditions: Venous Ulcers
Interventions: Blood Draw; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Thoracic Aortic Aneurysm, Penetrating Ulcers
Interventions: Relay Thoracic Stent-Graft; Device
Lead sponsor: Bolton Medical; Industry
Eligibility: 18 Years and older
U.S. locations: 15
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Gainesville, Florida + 12 more

Conditions: Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers
Interventions: Autologous PRP Gel, Autologous PRP Injections, Autologous PRP Gel plus PRP Injections, Standard Wound Care; Device · Procedure
Lead sponsor: Arteriocyte, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 6
States / cities: Bakersfield, California • Idaho Falls, Idaho • Englewood, New Jersey + 3 more

Conditions: Spinal Cord Injury
Interventions: Daily telephone calls, Weekly telephone calls; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Hines, Illinois • Cleveland, Ohio

Conditions: Diabetic Foot Ulcer, Venous Ulcer
Interventions: Low Frequency, Low Intensity Ultrasound, Sham Applicator; Device
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Foot Ulcer
Interventions: Photoacoustic imaging and multispectral imaging; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Venous Insufficiency
Interventions: Compression stocking 15-20mmHg, Compression stocking 20-30mmHg; Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Richmond Heights, Ohio

Conditions: Venous Leg Ulcer (VLU)
Interventions: Amnion-Intermediate-Chorion, Standard of Care (SOC); Other · Procedure
Lead sponsor: Cellution Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rocky Mount, North Carolina

Conditions: SCAD, Addison Disease, Ankylosing Spondylitis, Antiphospholipid Antibody Syndrome, Celiac Disease, Crohn Disease, Dermatomyositis, Polymyositis, Guillain-Barre Syndrome, Hepatitis, Autoimmune, Graves Disease, Hashimoto Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Polymyalgia Rheumatica, Primary Biliary Cirrhosis, Psoriasis, Rheumatoid Arthritis, Systemic Sclerosis, Sjögren Syndrome, Systemic Lupus Erythematosus, Takayasu Arteritis, Type 1 Diabetes Mellitus, Ulcerative Colitis, Uveitis, Vasculitis, Vitiligo, Raynaud
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 110 Years
Enrollment: 114 participants
Timeline: 1995 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Diabetic Foot Ulcer
Interventions: Transforming Powder Dressing, Standard of care topical wound agents and dressings; Device · Other
Lead sponsor: ULURU Inc.; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 12
States / cities: Washington D.C., District of Columbia • Winter Park, Florida • Baltimore, Maryland + 6 more

Conditions: Toenail Fungal Infection, Cellulitis, Pitted Keratolysis, Diabetic Foot Ulcer, Abscess
Interventions: Footwash; Combination Product
Lead sponsor: Data Collection Analysis Business Management; Other
Eligibility: Not listed
Enrollment: 5,000 participants
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Land O' Lakes, Florida

Conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ulcerative Colitis
Interventions: 75mg SHP647 (PF-00547659), 225mg SHP647 (PF-00547659); Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 66 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 29
States / cities: Scottsdale, Arizona • La Jolla, California • Orange, California + 26 more

Conditions: Pressure Ulcer, Bed Sore
Interventions: No Intervention; Other
Lead sponsor: Wound Vision; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Diabetic Foot, Ulcer Foot, Wound Heal
Interventions: Wound debridement, Wound closure matrix application; Procedure · Device
Lead sponsor: Polymedics Innovations Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Circleville, Ohio

Search by objective public record fields.

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

RB-PDT for Fusarium Keratitis: The LUMIERE Study

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

Clinical Implications of Genetic Variations of Venous Stasis Ulceration

Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds

Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D

Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes

Photoacoustic Imaging of Foot Wound

Compliance of Compression Therapy in Healed Venous Ulcerations

Nonhealing Venous Leg Ulcers Treated With a Standard of Care (SoC) Alone or Standard of Care and Dehydrated Human Placenta Tissue (dHPT) With Crossover

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care

A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Early Identification of Suspected Deep Tissue Injury (sDTI)

SDRM® vs. Collagen for Diabetic Foot Ulcers